Yellow Nail Syndrome: Case Report
DOI:
https://doi.org/10.29176/2590843X.1738Keywords:
Lymphedema, Pleural effusion, Respiratory disorders, Yellow nail syndromeAbstract
Abstract: Yellow nail syndrome is a poorly described entity, with an estimated prevalence of less than 1 / 100,000 people, presenting mainly in the sixth decade of life. The diagnosis is clinical, characterized by lymphedema, respiratory manifestations and yellow nails. Its etiology remains unknown; however, some hypotheses such as lymphatic dysfunction have been raised. Furthermore, there is a link between malignant neoplasms and this syndrome. No specific treatment has been described; however, the use of vitamin E, antifungals, zinc sulfate and macrolides has been considered like-promising therapy. We documented the case of an elderly adult who was admitted to the emergency with dyspnea, onychauxis and edema in the lower extremities.
Author Biographies
Santiago Mora Martínez, CUE AvH
Professor at the Alexander von Humboldt Business University Corporation. Resident of Critical Care and Intensive Medicine, University of Manizales.
Diego Alejandro Giraldo-Restrepo, National Autonomous University of Mexico
Internist from the National Autonomous University of Mexico
Laura Victoria Agudelo, Alexander von Humboldt Business University Corporation
Doctor of the Alexander von Humboldt Business University Corporation.
Laura Camila Barahona-Machado, University of Quindío
Doctor of the University of Quindío
References
Vignes S, Baran R. Yellow nail syndrome: a review. Orphanet J Rare Dis. 2017;12(1):42. https://doi.org/10.1186/s13023-017-0594-4.
Sil A, Chandra A, Banik B, Biswas SK, Chakraborty U. Yellow nail syndrome. J R Coll Physicians Edinb. 2021 Jun;51(2):166-167.
Heller J. Jadassohn's Handbuch der Haut und Geschlechtskrankheiten. Berlin: Julius Springer; 1927. Die Krankheiten der Nagel; p. 423.
Samman PD, White WF. The “yellow nail” syndrome. Br J Dermatol. 1964;76(4):153-7. https://doi.org/10.1111/j.1365-2133.1964.tb14499.x
Emerson P. Yellow nails, lymphoedema, and pleural effusions. Thorax. 1966;21(1):247-53. https://doi.org/10.1136/thx.21.3.247
Abdalla A, Jamous F. Yellow Nail Syndrome: A Case Presentation and a Review of Management Options. S D Med. 2021 Aug;74(8):368-371.
Kamatani M, Rai A, Hen H, Hayashi K, Aoki T, Umeyama K, et al. Yellow nail syndrome associated with mental retardation in two siblings. Br J Dermatol. 1978;99(3):329-33. https://doi.org/10.1111/j.1365-2133.1978.tb02005.x
Holzberg M, Piraccini BM. The nail in systemic disease. En: Baran & Dawber’s Diseases of the Nails and their Management. 5.a edición. Wiley; 2019. p. 481-573.
Kuwahara N, Homma T, Sagara H. Yellow nail syndrome with complete triad. Neth J Med. 2019 Feb;77(2):86.
Valdés L, Huggins JT, Gude F, Ferreiro L, ÁlvarezDobaño JM, Golpe A, et al. Characteristics of patients with yellow nail syndrome and pleural effusion. Respirology. 2014;19(7):985-92. https://doi.org/10.1111/resp.12357
Woodfield G, Nisbet M, Jacob J, Mok W, Loebinger MR, Hansell DM, et al. Bronchiectasis in yellow nail syndrome. Respirology. 2017;22(1):101-7. https://doi.org/10.1111/resp.12866
Li S, Huang H, Xu K, Xu ZJ. [Respiratory manifestations of yellow nail syndrome: report of two cases and literature review]. Zhonghua Jie He He Hu Xi Za Zhi. 2018 Mar 12;41(3):201-206. Chinese.
Robles Marhuenda Á, Molina Collada J, Arnalich Fernández F. Yellow nails syndrome. Rev Clin Esp (Barc). 2021 Oct;221(8):491-492. doi: 10.1016/j. rceng.2019.07.020.
Rockson SG. Yellow Nail Syndrome: A Mystery, Partially Solved. Lymphat Res Biol. 2018;16(4):329. https://doi.org/10.1089/lrb.2018.29050.sr
Abid N, Loukil M, Mahmoud N, Badri I, Bouzaidi K, Ghrairi H. Yellow nail syndrome: a genetic Disorder? Tunis Med. 2021 Avril;99(4):475-477.
Matsubayashi S, Suzuki M, Suzuki T, Shiozawa A, Kobayashi K, Ishii S, Iikura M, Izumi S, Kudo K, Sugiyama H. Effectiveness of clarithromycin in patients with yellow nail syndrome. BMC Pulm Med. 2018 Aug 15;18(1):138.
Nakabayashi H, Sagara H, Usukura N, Yoshimitsu K, Imamura T, Seta T, et al. Effect of somatostatin on the flow rate and triglyceride levels of thoracic duct lymph in normal and vagotomized dogs. Diabetes. 1981;30(5):440-5. https://doi.org/10.2337/diab.30.5.440
How to Cite
Downloads
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Revista de la Asociación Colombiana de Dermatología y Cirugía Dermatológica
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
| Article metrics | |
|---|---|
| Abstract views | |
| Galley vies | |
| PDF Views | |
| HTML views | |
| Other views | |
